Recognizing and Managing Side Effects of Androgen Deprivation Therapy (ADT)
Alicia K. Morgans, MD, MPH, Associate Professor of Medicine in Hematology and Oncology at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, discusses the side effects of androgen deprivation therapy (ADT) and how urologists can mitigate them. She observes that up to 40% of non-metastatic prostate cancer patients are treated with ADT, and those patients tend to be older and have more comorbidities. Studies have suggested that comorbidities and advanced age interact with ADT to increase risk of cardiovascular disease and diabetes. ADT is also associated with increased risk of depression, cognitive changes, and possibly dementia, as well as greater frailty in patients. Urologists should be aware of these side effects so that they can assess their patients’ risk and plan accordingly with multidisciplinary teams to reduce mortality and morbidity and improve quality of life.
Видео Recognizing and Managing Side Effects of Androgen Deprivation Therapy (ADT) канала Grand Rounds in Urology
Видео Recognizing and Managing Side Effects of Androgen Deprivation Therapy (ADT) канала Grand Rounds in Urology
Показать
Комментарии отсутствуют
Информация о видео
14 апреля 2020 г. 19:21:17
00:19:56
Другие видео канала
![Metabolic Side Effects of ADT](https://i.ytimg.com/vi/YYe0ym5IxKo/default.jpg)
![Testosterone Recovery Profiles after Cessation of Androgen Deprivation Therapy](https://i.ytimg.com/vi/u4TN9mCHlg4/default.jpg)
![Diet and Prostate Cancer—Now What?](https://i.ytimg.com/vi/_W3bA_gzX3Q/default.jpg)
![Androgen Deprivation Therapy: A Closer Review of the Role of Anti-Androgens](https://i.ytimg.com/vi/vDh-zotH2w8/default.jpg)
![Update on Brachytherapy for Prostate Cancer 2020](https://i.ytimg.com/vi/T-GYWbYZGTQ/default.jpg)
![Hormone Therapy & Advanced Therapies for Prostate Cancer, Celestia Higano, MD | 2021 Mid-Year Update](https://i.ytimg.com/vi/ClrbnTmJohg/default.jpg)
![Androgen Deprivation Therapy for Prostate Cancer and You](https://i.ytimg.com/vi/ULjmfiCxqAM/default.jpg)
![The ABCs of Androgen Deprivation Therapy](https://i.ytimg.com/vi/tAVyG_r94NE/default.jpg)
![Long term Morbidity Mortality of ADT and Radiation Therapy](https://i.ytimg.com/vi/0CnbyiRGes8/default.jpg)
![Imaging Tools for Improving Risk Assessment and Patient Selection for Biopsy](https://i.ytimg.com/vi/5mm-UT2kbPw/default.jpg)
![Which Should We Use Brachytherapy Monotherapy Or Combined EBRT and Brachytherapy](https://i.ytimg.com/vi/VWC6H1UpRHE/default.jpg)
![Nutrition and Prostate Cancer What We Think We Know and What We Actually Know](https://i.ytimg.com/vi/ayjYnZy5OVM/default.jpg)
![The Role of Molecular Imaging to Improve Cancer Control Post-Prostatectomy](https://i.ytimg.com/vi/aK83e5zGa9A/default.jpg)
![Abiraterone in Metastatic Prostate Cancer](https://i.ytimg.com/vi/ZaMzLf-Z5KU/default.jpg)
![Intermittent HT, Quality of Life, and Testosterone Recovery](https://i.ytimg.com/vi/_et0sSGLNTA/default.jpg)
![Cancer Treatment: IMRT (Radiation Therapy)](https://i.ytimg.com/vi/_moypMx05Fw/default.jpg)
![Cancer cachexia and sarcopenia in GI cancer: Mechanism and ways to interfere with it](https://i.ytimg.com/vi/NfzqCX8LGgs/default.jpg)
![An Overview of Prostate Cancer - Creative Biolabs](https://i.ytimg.com/vi/RPNDBWDCU_c/default.jpg)
![ZERO Webinar: What You Need to Know About ADT](https://i.ytimg.com/vi/_WyQmxqOd1I/default.jpg)
![PCa Commentary May 2021 - PSMA Targeted RadioIigand Therapy for Metastatic Prostate Cancer](https://i.ytimg.com/vi/7KEJLoXIyDA/default.jpg)